RWM
JNJ icon

Ruedi Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Ruedi Wealth Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-248
Closed -$41.1K – 197
2025
Q1 		$41.1K Hold
248
– – 0.01% 94
2024
Q4 		$35.8K Hold
248
– – 0.01% 98
2024
Q3 		$40.1K Sell
248
-33
-12% -$5.26K 0.01% 97
2024
Q2 		$41.1K Buy
281
+34
+14% +$5.06K 0.02% 94
2024
Q1 		$39K Buy
247
+62
+34% +$9.87K 0.02% 94
2023
Q4 		$29K Hold
185
– – 0.01% 99
2023
Q3 		$28.8K Buy
185
+1
+0.5% +$165 0.02% 96
2023
Q2 		$30.5K Hold
184
– – 0.02% 94
2023
Q1 		$28.4K Sell
184
-52
-22% -$8.4K 0.02% 112
2022
Q4 		$41.7K Buy
+236
New +$40.7K 0.03% 78

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ruedi Wealth Management's JNJ Position: Q2 2025 in Review

Ruedi Wealth Management sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 248 shares — an estimated $41.1K sold.

Ruedi Wealth Management first reported a position in JNJ in Q4 2022 and held it in 10 quarters. The position peaked at $41.7K in Q4 2022. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Ruedi Wealth Management reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Ruedi Wealth Management sold 248 Johnson & Johnson shares in Q2 2025, an estimated $41.1K.
  • Ruedi Wealth Management first reported a position in Johnson & Johnson in Q4 2022 and held it in 10 quarters.
  • Ruedi Wealth Management's Johnson & Johnson position peaked at $41.7K in Q4 2022.
  • 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Ruedi Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.